Pα+ Psychedelic Patent Analysis: A Mebufotenin Melee (Dec ’23 & Jan ’24)

In our latest Psychedelic Patent Analysis, we take a deep dive into recent patent-related developments at two companies that are both pursuing 5-MeO-DMT for treatment-resistant depression (TRD): GH Research and Beckley Psytech. This case study raises questions not only about how these two specific companies’ IP might shake out, but also about how other types of exclusivity—such as data and market…

Source

UnitedHealth executive to head health insurance group AHIP

WASHINGTON — An executive at insurance giant UnitedHealth Group is slated to be the next leader of the health insurance industry’s largest lobbying group, the

December 11, 2023

Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation – Biotech Investments

EQS-News: Biotest AG / Key word(s): Research Update Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation 28.11.2023

November 29, 2023

Opinion | What the Astronomical Rise in Incarceration Means for Women’s Health

Shuford is a medical student. Spencer is an assistant professor of medicine. As a physician and medical student, we have bore witness to much preventable

November 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.